Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 10, 2019 Off

Antibiotic Resistance Markets 2017-2018 & 2019-2023 – Therapeutics By Pathogen and Therapy Type With Situation Analysis, Executive & Investor Guides – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Antibiotic Resistance Markets – Therapeutics By Pathogen and Therapy Type With Situation Analysis, Executive & Investor Guides &…

June 10, 2019 Off

Acceleron Announces Retirement of Director and Co-Founder Tom Maniatis

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to…

June 10, 2019 Off

Flex Pharma Announces that ISS and Glass Lewis Recommend Shareholders Vote “FOR” All Agenda Items relating to Flex’s Strategic Merger with Salarius Pharmaceuticals

By BusinessWire

BOSTON–(BUSINESS WIRE)–Flex Pharma, Inc. (Nasdaq: FLKS) today announced that Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis recommend that shareholders…

June 10, 2019 Off

Aerpio Initiates Phase 1b Clinical Trial of Topical Ocular Formulation of AKB-9778 for Primary Open Angle Glaucoma

By BusinessWire

CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases…

June 10, 2019 Off

F-star appoints Dr Louis Kayitalire as Chief Medical Officer

By BusinessWire

CAMBRIDGE, England–(BUSINESS WIRE)–F-star, a clinical-stage biopharmaceutical company delivering tetravalent bispecific antibodies for a paradigm-shift in cancer therapy, today announces the…

June 10, 2019 Off

Tetraphase Pharmaceuticals Announces New XERAVA™ (eravacycline) Data at the 39th Annual Surgical Infection Society Meeting

By BusinessWire

-Study Examines Microbiology and Hospitalization Outcomes Among Complicated Intra-Abdominal Infection Patients- -Data Underscore XERAVA’s Role as an Empiric Treatment Option…

June 10, 2019 Off

Merck to Acquire Tilos Therapeutics

By BusinessWire

Merck Gains Portfolio of Investigational Antibodies Modulating TGFβ KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United…

June 10, 2019 Off

Global Hospital Care Partnering Deal Trends, Players and Financials 2014-2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Hospital Care Partnering 2014-2019: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global…

June 10, 2019 Off

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Hematology Partnering 2014-2019: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Hematology…

June 10, 2019 Off

Global Immunology Partnering Deal Trends, Players and Financials Directory 2014-2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Immunology Partnering 2014-2019: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Immunology…

Posts pagination

Previous 1 … 3,114 3,115 3,116 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine